These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 31456471)

  • 1. Cardiovascular nanomedicine: the route ahead.
    Iafisco M; Alogna A; Miragoli M; Catalucci D
    Nanomedicine (Lond); 2019 Sep; 14(18):2391-2394. PubMed ID: 31456471
    [No Abstract]   [Full Text] [Related]  

  • 2. Nanomedicine and drug delivery.
    Wei C; Wei W; Morris M; Kondo E; Gorbounov M; Tomalia DA
    Med Clin North Am; 2007 Sep; 91(5):863-70. PubMed ID: 17826106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanomedicine applied to cardiovascular diseases: latest developments.
    Martín Giménez VM; Kassuha DE; Manucha W
    Ther Adv Cardiovasc Dis; 2017 Apr; 11(4):133-142. PubMed ID: 28198204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanotherapeutic Solutions for Cardiovascular Disease.
    Cooke JP; Atkins J
    Methodist Debakey Cardiovasc J; 2016 Sep; 12(3):132-133. PubMed ID: 27826365
    [No Abstract]   [Full Text] [Related]  

  • 5. Perspective and potential of oral lipid-based delivery to optimize pharmacological therapies against cardiovascular diseases.
    Rao S; Tan A; Thomas N; Prestidge CA
    J Control Release; 2014 Nov; 193():174-87. PubMed ID: 24852093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic and Therapeutic Nanoparticles in Cardiovascular Diseases.
    Tyler PD; Kang PM
    Curr Pharm Des; 2015; 21(42):6070-80. PubMed ID: 26503151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Editorial.
    Hennink WE; Paulusse JM
    J Control Release; 2016 Dec; 244(Pt B):137-138. PubMed ID: 27989301
    [No Abstract]   [Full Text] [Related]  

  • 8. Recent advancements in the cardiovascular drug carriers.
    Singh B; Garg T; Goyal AK; Rath G
    Artif Cells Nanomed Biotechnol; 2016; 44(1):216-25. PubMed ID: 25046615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanotechnology for the diagnosis and treatment of diseases.
    Azzawi M; Seifalian A; Ahmed W
    Nanomedicine (Lond); 2016 Aug; 11(16):2025-7. PubMed ID: 27509317
    [No Abstract]   [Full Text] [Related]  

  • 10. Ultrasound techniques for drug delivery in cardiovascular medicine.
    Landini L; Santarelli MF; Landini L; Positano V
    Curr Drug Discov Technol; 2008 Dec; 5(4):328-32. PubMed ID: 19075613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimuli-Responsive Programmed Specific Targeting in Nanomedicine.
    Wang S; Huang P; Chen X
    ACS Nano; 2016 Mar; 10(3):2991-4. PubMed ID: 26881288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoparticle Based Treatment for Cardiovascular Diseases.
    Gupta P; Garcia E; Sarkar A; Kapoor S; Rafiq K; Chand HS; Jayant RD
    Cardiovasc Hematol Disord Drug Targets; 2019; 19(1):33-44. PubMed ID: 29737265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smart chemistry-based nanosized drug delivery systems for systemic applications: A comprehensive review.
    Ramasamy T; Ruttala HB; Gupta B; Poudel BK; Choi HG; Yong CS; Kim JO
    J Control Release; 2017 Jul; 258():226-253. PubMed ID: 28472638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of drug delivery systems based on layered hydroxides for nanomedicine.
    Barahuie F; Hussein MZ; Fakurazi S; Zainal Z
    Int J Mol Sci; 2014 May; 15(5):7750-86. PubMed ID: 24802876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How are we applying nanogel composites in biomedicine?
    Kar M; Molina M; Calderón M
    Nanomedicine (Lond); 2017 Jul; 12(14):1627-1630. PubMed ID: 28635377
    [No Abstract]   [Full Text] [Related]  

  • 16. Nanomedicine opportunities for cardiovascular disease with perfluorocarbon nanoparticles.
    Lanza GM; Winter PM; Caruthers SD; Hughes MS; Cyrus T; Marsh JN; Neubauer AM; Partlow KC; Wickline SA
    Nanomedicine (Lond); 2006 Oct; 1(3):321-9. PubMed ID: 17716162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Value of pharmacokinetic studies in cardiology].
    Belousov IuB
    Kardiologiia; 1989 May; 29(5):5-11. PubMed ID: 2770087
    [No Abstract]   [Full Text] [Related]  

  • 18. Nanotechnological strategies for nerve growth factor delivery: Therapeutic implications in Alzheimer's disease.
    Faustino C; Rijo P; Reis CP
    Pharmacol Res; 2017 Jun; 120():68-87. PubMed ID: 28351757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nano-medicine and Vascular Endothelial Dysfunction: Options and Delivery Strategies.
    Taneja G; Sud A; Pendse N; Panigrahi B; Kumar A; Sharma AK
    Cardiovasc Toxicol; 2019 Feb; 19(1):1-12. PubMed ID: 30448914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Programmable nanomedicine: synergistic and sequential drug delivery systems.
    Pacardo DB; Ligler FS; Gu Z
    Nanoscale; 2015 Feb; 7(8):3381-91. PubMed ID: 25631684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.